Journal of Neurology Research, ISSN 1923-2845 print, 1923-2853 online, Open Access |
Article copyright, the authors; Journal compilation copyright, J Neurol Res and Elmer Press Inc |
Journal website https://www.neurores.org |
Original Article
Volume 12, Number 3, October 2022, pages 121-127
The Impact of Atrial Fibrillation on the Outcome of Ischemic Stroke Treated With Thrombolysis or Endovascular Therapy
Figure
Tables
Variables | AF- (n = 524) | AF+ (n = 196) | P value |
---|---|---|---|
aMeasure is continuous (results are mean and standard deviation). AF: atrial fibrillation; AF-: without atrial fibrillation; AF+: with atrial fibrillation; EVT: endovascular therapy; mRS: modified Rankin Scale; NIHSS: National Institutes of Health Stroke Scale; SBP: systolic blood pressure; TIA: transient ischemic attack. | |||
Agea | 66.9 (15.2) | 78.2 (12.5) | < 0.0001 |
Sex (female) | 227 (43.3%) | 109 (55.6%) | 0.004 |
White | 417 (82.7%) | 166 (88.8%) | 0.03 |
Asian | 28 (5.6%) | 10 (5.3%) | |
Black/African American | 53 (10.5%) | 7 (3.7%) | |
Native American | 2 (0.4%) | 3 (1.6%) | |
Pacific Islander | 1 (0.2%) | 1 (0.5%) | |
Not Hispanic/Latino | 412 (78.6%) | 155 (79.1%) | 0.79 |
Hispanic/Latino | 108 (20.6%) | 38 (19.4%) | |
Current smoker | 84 (16%) | 6 (3.1%) | < 0.0001 |
Hypertension | 348 (66.4%) | 146 (74.5%) | 0.10 |
Diabetes | 128 (24.4%) | 42 (21.4%) | 0.46 |
Coronary artery disease | 94 (17.9%) | 46 (23.5%) | 0.18 |
Congestive heart failure | 50 (9.5%) | 42 (21.4%) | 0.0001 |
Stroke/TIA | 122 (23.3%) | 46 (23.5%) | 0.57 |
Anticoagulants | 4 (0.8%) | 6 (3.1%) | 0.05 |
Baseline SBPa | 150.7 (25.6) | 150.6 (26) | 0.93 |
Baseline glucosea | 133 (46.6) | 141.3 (64.8) | 0.11 |
NIHSS > 5 at baseline | 338 (64.6%) | 151 (77.4%) | 0.001 |
Baseline mRS > 2 | 46 (9%) | 39 (20.3%) | < 0.0001 |
EVT | 61 (11.6%) | 39 (19.9%) | 0.006 |
Thrombolysis | 435 (83%) | 140 (71.4%) | 0.0008 |
Thrombolysis and EVT | 28 (5.3%) | 17 (8.7%) | 0.14 |
Variables | TICI < 2b | sICH | ||
---|---|---|---|---|
OR (CI) | P | OR (CI) | P | |
aFemale. bNever smoked or ex-smoker. cSeverity was defined as baseline NIHSS > 5. dDisability was defined as baseline modified Rankin Scale > 2. P-values less than 0.0001 are reported as zero. TICI: thrombolysis in cerebral infarction; sICH: symptomatic intracranial hemorrhage; CHF: congestive heart failure; OR: odds ratio; CI: confidence interval; SBP: systolic blood pressure; AF+: with atrial fibrillation. | ||||
Age | 0.96 (0.9 - 1.02) | 0.1637 | 1.02 (0.99 - 1.06) | 0.1909 |
Sexa | 0.19 (0.04 - 0.92) | 0.0392 | 0.65 (0.26 - 1.64) | 0.365 |
SBP | 1.03 (1 - 1.06) | 0.0429 | 1.01 (0.99 - 1.02) | 0.515 |
Smokersb | 0.22 (0.02 - 3.01) | 0.2587 | 2.04 (0.52 - 7.93) | 0.3059 |
Glucose | 1 (0.99 - 1.02) | 0.5451 | 1 (1 - 1.01) | 0.3189 |
Severityc | 4.71 (0.44 - 50.88) | 0.2015 | 2.99 (0.84 - 10.61) | 0.0899 |
Disabilityd | 0.91 (0.14 - 6.06) | 0.9217 | 0.39 (0.08 - 1.81) | 0.2285 |
CHF | 1.97 (0.26 - 14.96) | 0.5138 | 1.78 (0.61 - 5.26) | 0.294 |
Anticoagulants | 0.64 (0.05 - 7.9) | 0.7306 | 0 (0 - Inf) | 0.9878 |
AF+ | 1.19 (0.29 - 4.84) | 0.8097 | 1.18 (0.44 - 3.17) | 0.7433 |
Variables | Discharge disposition | Modified Rankin Scale | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospice/SNF/death | In-hospital death | Hospice/SNF | 0 - 2 vs. 3 - 6 | 0 - 2 vs. 3 - 5 | 0 - 2 vs. 6 (death) | |||||||
OR (CI) | P | OR (CI) | P | OR (CI) | P | OR (CI) | P | OR (CI) | P | OR (CI) | P | |
aFemale. bNever smoked or ex-smoker. cSeverity was defined as baseline NIHSS > 5. dDisability was defined as baseline modified Rankin Scale > 2. P-values less than 0.0001 are reported as zero. SBP: systolic blood pressure; AF+: with atrial fibrillation; CHF: congestive heart failure; OR: odds ratio; CI: confidence interval; SNF: skilled nursing facility; TICI: thrombolysis in cerebral infarction. | ||||||||||||
Age | 1.04 (1.02 - 1.06) | 0 | 1.04 (1.01 - 1.06) | 0.0117 | 1.04 (1.02 - 1.07) | 0 | 0.97 (0.96 - 0.98) | 0 | 0.98 (0.96 - 0.99) | 0.0029 | 0.95 (0.93 - 0.97) | 0 |
Sexa | 1.03 (0.67 - 1.57) | 0.8913 | 1.15 (0.59 - 2.22) | 0.6846 | 1.03 (0.63 - 1.68) | 0.9026 | 1.02 (0.71 - 1.46) | 0.9315 | 1.05 (0.71 - 1.55) | 0.8098 | 0.81 (0.46 - 1.42) | 0.4615 |
SBP | 1.01 (1.01 - 1.02) | 0.0015 | 1.01 (1 - 1.02) | 0.1129 | 1.02 (1.01 - 1.03) | 0.0016 | 1 (0.99 - 1) | 0.2487 | 1 (0.99 - 1) | 0.3718 | 1 (0.98 - 1.01) | 0.4421 |
Smokersb | 1.1 (0.55 - 2.19) | 0.7904 | 0.4 (0.09 - 1.84) | 0.2382 | 1.49 (0.7 - 3.16) | 0.2982 | 0.85 (0.5 - 1.46) | 0.5569 | 0.77 (0.44 - 1.36) | 0.3645 | 1.53 (0.56 - 4.18) | 0.4086 |
Glucose | 1 (1 - 1) | 0.3601 | 1 (1 - 1.01) | 0.1462 | 1 (1 - 1) | 0.7929 | 1 (1 - 1) | 0.3204 | 1 (1 - 1) | 0.4 | 1 (1 - 1) | 0.8785 |
Severityc | 6.61 (3.68 - 11.87) | 0 | 6.73 (2.51 - 18.05) | 0.0002 | 7.06 (3.52 - 14.13) | 0 | 0.22 (0.15 - 0.33) | 0 | 0.28 (0.18 - 0.43) | 0 | 0.12 (0.05 - 0.26) | 0 |
Disabilityd | 1.24 (0.7 - 2.19) | 0.4639 | 0.9 (0.36 - 2.26) | 0.8298 | 1.41 (0.75 - 2.64) | 0.2819 | 0.13 (0.06 - 0.28) | 0 | 0.15 (0.07 - 0.35) | 0 | 0.11 (0.04 - 0.27) | 0 |
CHF | 1.87 (1.05 - 3.32) | 0.033 | 1.68 (0.71 - 3.98) | 0.2395 | 2.04 (1.07 - 3.9) | 0.0308 | 0.7 (0.41 - 1.2) | 0.1997 | 0.67 (0.37 - 1.21) | 0.1864 | 0.66 (0.3 - 1.43) | 0.2923 |
Anticoagulants | 3.7 (0.75 - 18.27) | 0.1079 | 4.77 (0.4 - 56.63) | 0.2154 | 3.85 (0.66 - 22.53) | 0.1354 | 1.25 (0.31 - 5.11) | 0.7521 | 1.82 (0.34 - 9.74) | 0.4839 | 1.36 (0.14 - 12.84) | 0.7906 |
AF+ | 1 (0.63 - 1.59) | 0.9998 | 0.95 (0.46 - 1.97) | 0.8932 | 0.96 (0.56 - 1.63) | 0.8693 | 0.73 (0.48 - 1.11) | 0.1403 | 0.75 (0.47 - 1.2) | 0.2284 | 0.67 (0.37 - 1.21) | 0.1853 |